MEDX HEALTH CORP (MDX.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:MDX • CA5850901037

0.055 CAD
0 (0%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to MDX. MDX was compared to 16 industry peers in the Health Care Equipment & Supplies industry. MDX may be in some trouble as it scores bad on both profitability and health. MDX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year MDX has reported negative net income.
  • MDX had a negative operating cash flow in the past year.
  • In the past 5 years MDX always reported negative net income.
  • MDX had a negative operating cash flow in each of the past 5 years.
MDX.CA Yearly Net Income VS EBIT VS OCF VS FCFMDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -422.39%, MDX is doing worse than 68.75% of the companies in the same industry.
Industry RankSector Rank
ROA -422.39%
ROE N/A
ROIC N/A
ROA(3y)-597.39%
ROA(5y)-591.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDX.CA Yearly ROA, ROE, ROICMDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

  • The Gross Margin of MDX (33.60%) is worse than 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of MDX has declined.
  • The Profit Margin and Operating Margin are not available for MDX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.51%
GM growth 5Y-6.59%
MDX.CA Yearly Profit, Operating, Gross MarginsMDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • MDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MDX has more shares outstanding
  • Compared to 5 years ago, MDX has more shares outstanding
  • Compared to 1 year ago, MDX has an improved debt to assets ratio.
MDX.CA Yearly Shares OutstandingMDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
MDX.CA Yearly Total Debt VS Total AssetsMDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • MDX has an Altman-Z score of -78.59. This is a bad value and indicates that MDX is not financially healthy and even has some risk of bankruptcy.
  • MDX has a Altman-Z score of -78.59. This is in the lower half of the industry: MDX underperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -78.59
ROIC/WACCN/A
WACC9.65%
MDX.CA Yearly LT Debt VS Equity VS FCFMDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

2.3 Liquidity

  • A Current Ratio of 0.10 indicates that MDX may have some problems paying its short term obligations.
  • MDX has a Current ratio of 0.10. This is in the lower half of the industry: MDX underperforms 75.00% of its industry peers.
  • A Quick Ratio of 0.06 indicates that MDX may have some problems paying its short term obligations.
  • The Quick ratio of MDX (0.06) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.06
MDX.CA Yearly Current Assets VS Current LiabilitesMDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for MDX have decreased strongly by -54.10% in the last year.
  • MDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.09%.
  • The Revenue for MDX have been decreasing by -10.66% on average. This is quite bad
EPS 1Y (TTM)-54.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.38%
Revenue 1Y (TTM)42.09%
Revenue growth 3Y-4.55%
Revenue growth 5Y-10.66%
Sales Q2Q%49.34%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MDX.CA Yearly Revenue VS EstimatesMDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
MDX.CA Yearly EPS VS EstimatesMDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 -0 -0 -0.01 -0.01 -0.01

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MDX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDX.CA Price Earnings VS Forward Price EarningsMDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDX.CA Per share dataMDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MDX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDX HEALTH CORP

TSX-V:MDX (2/5/2026, 7:00:00 PM)

0.055

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-01
Earnings (Next)04-27
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners26.75%
Ins Owner ChangeN/A
Market Cap18.04M
Revenue(TTM)522.90K
Net Income(TTM)-5.30M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 34.49
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -422.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.6%
FCFM N/A
ROA(3y)-597.39%
ROA(5y)-591.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.51%
GM growth 5Y-6.59%
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.06
Altman-Z -78.59
F-Score3
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.09%
Revenue growth 3Y-4.55%
Revenue growth 5Y-10.66%
Sales Q2Q%49.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.8%
OCF growth 3YN/A
OCF growth 5YN/A

MEDX HEALTH CORP / MDX.CA FAQ

What is the fundamental rating for MDX stock?

ChartMill assigns a fundamental rating of 0 / 10 to MDX.CA.


What is the valuation status for MDX stock?

ChartMill assigns a valuation rating of 0 / 10 to MEDX HEALTH CORP (MDX.CA). This can be considered as Overvalued.


Can you provide the profitability details for MEDX HEALTH CORP?

MEDX HEALTH CORP (MDX.CA) has a profitability rating of 0 / 10.